Daclatasvir [CAS 1009119-64-5]
Partner: MedChemexpress LLC
| CAS No: | 1009119-64-5 |
| Applications: | COVID-19-anti-virus |
| MW: | 738.88 |
| Formula: | C40H50N8O6 |
| SMILES: | O=C([C@@H](NC(OC)=O)C(C)C)N1CCC[C@H]1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C5=CN=C([C@@H]6CCCN6C([C@@H](NC(OC)=O)C(C)C)=O)N5)C=C4 |
| Purity: | 98.76 |
| Description: | Daclatasvir (BMS-790052) is a potent and orally active HCV NS5A protein inhibitor with EC50s range of 9-146 pM for multiple HCV replicon genotypes. Daclatasvir is also a organic anion transporting polypeptide 1B (OATP1B) and OATP1B3 inhibitor with IC50s of 1.5 �M and 3.27 �M, respectively[1][2][3]. |
| Shipping Conditions: | Ship at ambient |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
